Victory Capital Management’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,801
Closed -$247K 2447
2025
Q3
$247K Sell
16,801
-26,290
-61% -$268K ﹤0.01% 2181
2025
Q2
$423K Buy
43,091
+26,178
+155% +$217K ﹤0.01% 2086
2025
Q1
$123K Buy
16,913
+2,944
+21% +$25.7K ﹤0.01% 2287
2024
Q4
$109K Buy
13,969
+1,437
+11% +$11.8K ﹤0.01% 2329
2024
Q3
$92.7K Buy
12,532
+668
+6% +$5.62K ﹤0.01% 2332
2024
Q2
$95K Buy
11,864
+454
+4% +$4.05K ﹤0.01% 2304
2024
Q1
$133K Buy
+11,410
New +$126K ﹤0.01% 2266
2023
Q4
Sell
-555,773
Closed -$8.58M 2564
2023
Q3
$8.58M Sell
555,773
-190,248
-26% -$3.19M 0.01% 1077
2023
Q2
$14.1M Buy
746,021
+689,061
+1,210% +$12.1M 0.02% 906
2023
Q1
$868K Buy
+56,960
New +$743K ﹤0.01% 1770
2020
Q2
Sell
-1,956
Closed -$50K 2754
2020
Q1
$50K Buy
+1,956
New +$57.2K ﹤0.01% 2758

Other funds holding ETNB

Victory Capital Management's ETNB Position: Q4 2025 in Review

Victory Capital Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 16,801 shares — an estimated $247K sold.

Victory Capital Management first reported a position in ETNB in Q1 2020 and held it in 11 quarters. The position peaked at $14.1M in Q2 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Victory Capital Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Victory Capital Management sold 16,801 89bio shares in Q4 2025, an estimated $247K.
  • Victory Capital Management first reported a position in 89bio in Q1 2020 and held it in 11 quarters.
  • Victory Capital Management's 89bio position peaked at $14.1M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Victory Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.